These results indicate that miR-146b inhibits tumor growth through p110β/PI3K/AKT-mediated immune activation and that p110β/PI3K/AKT inhibition reverses these effects by polarizing macrophages toward a proinflammatory phenotype. The gene discussed is AKT1; the disease is neoplasm.